By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Rhizen Pharmaceuticals S.A. 


Fritz-Courvoisier 40
CH-2300 La Chaux-de-Fonds      Switzerland
Phone: 41-32-967-9595 Fax: 41-32-967-9596


SEARCH JOBS


Industry
Pharmaceutical






Company News
Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of RP6530 (Dual PI3K Delta/Gamma Inhibitor) In Multiple Myeloma 11/18/2014 6:08:25 PM
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014 9:10:10 AM
Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of Their First-In-Class Inflammation Assets, RP6503 And RP3128 For Treatment Of Various Respiratory Diseases 9/3/2014 7:19:31 AM
Rhizen Pharmaceuticals S.A. Announces Initiation Of A "First In Human" Phase-1 Trial Of RP6530, A Dual PI3K Delta/Gamma Inhibitor, In Patients With Hematological Malignancies 12/6/2013 9:43:09 AM
Rhizen Pharmaceuticals S.A. Announces Preclinical Presentations On RP6530, A Dual PI3K Delta/Gamma Inhibitor, For The Treatment Of Hematological Malignancies At The 55th Annual Meeting Of The American Society of Hematology, 2013 11/19/2013 9:12:43 AM
Rhizen Pharmaceuticals S.A. Announces a Scientific Presentation on the PI3K-Delta Inhibitor, TGR-1202, at the XV International Workshop on Chronic Lymphocytic Leukemia at Cologne, Germany 9/9/2013 9:23:04 AM
Rhizen Pharmaceuticals S.A. Announces Scientific Presentations on the Therapeutic Potential of Their Lead Dual PI3K Delta/Gamma Inhibitor and CRAC Channel Inhibitor at the ERS Annual Conference at Barcelona, Spain, 7-11 September 2013 9/6/2013 9:41:45 AM
Rhizen Pharmaceuticals S.A. Announces a Scientific Presentation on the Therapeutic Potential of Their Lead Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphomas at the 18th Congress of European Hematology Association, 13-16 June 2013 6/12/2013 8:45:46 AM
TG Therapeutics, Inc. (MHA), Rhizen Pharmaceuticals S.A. Ink Deal Worth Up to $250 Million 8/16/2012 8:13:26 AM
//-->